Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,009,271
-$206,310 QoQ
Shares Held
25,457
-0.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Fiduciary Trust Co holds $5,262,233 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (57.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
25,457 | $3,009,271 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
14,714 | $760,565 | |
| 3 | HLN |
Haleon plc
|
67,965 | $680,328 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
42,955 | $408,931 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,005 | $264,138 | |
| 6 | AKBA |
Akebia Therapeutics, Inc.
|
100,000 | $139,000 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,009,271 | 25,457 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,215,581 | 25,557 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,031,798 | 34,389 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,100,295 | 39,117 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,389,656 | 44,881 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,998,623 | 55,230 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,978,792 | 56,192 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,126,883 | 52,647 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,325,162 | 55,110 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $10,610,413 | 53,759 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $9,017,034 | 51,828 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,575,023 | 49,794 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $7,963,820 | 47,848 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,872,608 | 46,896 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,342,807 | 42,773 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,498,528 | 43,624 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,145,483 | 48,494 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $9,261,181 | 37,951 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,973,313 | 35,919 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,033,218 | 32,374 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,405,817 | 27,977 | Shares | Sole | 2021-05-19 | |
| 2020-12-31 | $4,354,966 | 26,314 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $4,340,962 | 26,250 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,177,956 | 23,190 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,712,165 | 23,045 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||